MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 166241 to 166260 of 166,322 approvalsPage 8313 of 8317

阿托伐他汀钙

Approval Number: 国药准字H20143160
Registration: May 17, 2019

Cefdinir Tablets

Approval Number: 国药准字H20140072
Registration: May 17, 2019

Levofloxacin Lactate Tablets

Approval Number: 国药准字H20093726
Registration: May 17, 2019

醋酸奥曲肽

Approval Number: 国药准字H20090277
Registration: May 17, 2019

盐酸安妥沙星

Approval Number: 国药准字H20090199
Registration: May 16, 2019

fufang danshen tablet

Approval Number: 国药准字Z20093280
Registration: May 16, 2019

Vitamin B2 Tablets

Approval Number: 国药准字H41021586
Registration: May 15, 2019

Gefitinib Tablets

Approval Number: 国药准字H20193135
Registration: May 15, 2019

Apixaban Tablets

Approval Number: 国药准字H20193134
Registration: May 15, 2019

Glecaprevir and Pibrentasvir Tablets

Approval Number: H20190035
Registration: May 15, 2019

Vinpocetine Injection

Approval Number: 国药准字H20193133
Registration: May 15, 2019

安宫止血丸

Approval Number: 国药准字Z20090831
Registration: May 14, 2019

炎可宁片

Approval Number: 国药准字Z20093217
Registration: May 14, 2019

北豆根分散片

Approval Number: 国药准字Z20090822
Registration: May 14, 2019

大风丸

Approval Number: 国药准字Z20093566
Registration: May 14, 2019

咽炎胶囊

Approval Number: 国药准字Z20090888
Registration: May 14, 2019

Policresulen Suppositories

Approval Number: 国药准字H20093713
Registration: May 14, 2019

四水合辅羧酶

Approval Number: 国药准字H20143317
Registration: May 14, 2019

胃舒宁片

Approval Number: 国药准字Z20090875
Registration: May 14, 2019

夏天无丸

Approval Number: 国药准字Z20090898
Registration: May 13, 2019

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.